FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 93 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $30,616,000 | +7.3% | 812,737 | -51.5% | 0.01% | 0.0% |
| Q4 2020 | $28,532,000 | +10707.6% | 1,677,382 | +2876.5% | 0.01% | – |
| Q3 2020 | $264,000 | -73.3% | 56,354 | -65.2% | 0.00% | – |
| Q2 2020 | $987,000 | +585.4% | 161,855 | +155.2% | 0.00% | – |
| Q1 2020 | $144,000 | +9.9% | 63,413 | +122.8% | 0.00% | – |
| Q4 2019 | $131,000 | +11.0% | 28,467 | -6.3% | 0.00% | – |
| Q3 2019 | $118,000 | -37.9% | 30,392 | -3.7% | 0.00% | – |
| Q2 2019 | $190,000 | -68.5% | 31,560 | -30.0% | 0.00% | – |
| Q1 2019 | $604,000 | +49.1% | 45,074 | +3.4% | 0.00% | – |
| Q4 2018 | $405,000 | -23.1% | 43,581 | +15.1% | 0.00% | – |
| Q3 2018 | $527,000 | -11.9% | 37,872 | +0.1% | 0.00% | – |
| Q2 2018 | $598,000 | +28.6% | 37,842 | +39.7% | 0.00% | – |
| Q1 2018 | $465,000 | +40.1% | 27,083 | +78.6% | 0.00% | – |
| Q4 2017 | $332,000 | -44.0% | 15,164 | +4.6% | 0.00% | – |
| Q3 2017 | $593,000 | +37.9% | 14,498 | +1.6% | 0.00% | – |
| Q2 2017 | $430,000 | -73.4% | 14,272 | -68.1% | 0.00% | -100.0% |
| Q1 2017 | $1,617,000 | -84.4% | 44,749 | -78.4% | 0.00% | -66.7% |
| Q4 2016 | $10,368,000 | +13.2% | 206,901 | +18.6% | 0.00% | 0.0% |
| Q3 2016 | $9,158,000 | +28.1% | 174,488 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $7,150,000 | +137.9% | 172,911 | +133.7% | 0.00% | +200.0% |
| Q1 2016 | $3,006,000 | +60020.0% | 73,978 | +33991.2% | 0.00% | – |
| Q2 2015 | $5,000 | -99.6% | 217 | -99.5% | 0.00% | – |
| Q4 2014 | $1,125,000 | – | 41,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 601,000 | $24,587,000 | 1.39% |
| HealthCor Management, L.P. | 1,010,930 | $41,357,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 86,500 | $3,535,000 | 1.38% |
| PURA VIDA INVESTMENTS, LLC | 75,000 | $3,068,000 | 0.90% |
| BB BIOTECH AG | 777,500 | $31,808,000 | 0.88% |
| AWM Investment Company, Inc. | 100,000 | $4,091,000 | 0.71% |
| Granite Point Capital Management, L.P. | 50,000 | $2,046,000 | 0.43% |
| Rock Springs Capital Management LP | 217,700 | $8,906,000 | 0.41% |
| Crestline Management, LP | 50,919 | $2,083,000 | 0.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,432,700 | $99,522,000 | 0.24% |